This result is well in line with the higher tumor mutational burden (TMB) of LCNEC compared to other lung cancers (52) and with the importance of PD-L1 expression on LCNEC cells and their microenvironment for patient outcome (53). The gene discussed is CD274; the disease is lung carcinoma.